To ascertain whether CD44 is associated with a particular clinicopathological feature and hormonal state, as well as whether it is an independent prognostic marker, this study was carried out to evaluate CD44 expression in instances of breast cancer. This evidence concerns the gene CD44 and breast carcinoma.